Pulished Date August, 2019
ID: 6223
Share on
Share on

Asia Pacific Ulcerative Colitis Market By Product (Monoclonal Antibodies, Biosimilars And Pharmaceuticals), By Type (Proctosigmoiditis, Ulcerative Proctitis, Pancolitis And Left Sided Colitis), By Route Of Administration (Oral And Injectable) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: August, 2019
ID: 6223
Pages: 145

Asia Pacific Ulcerative Colitis Market was worth USD 0.85 billion in 2018 and is projected to grow at a CAGR of 7.9%, to reach USD 1.25 billion by 2023 Ulcerative Colitis is an inflammatory bowel disease that results in ulcers and inflammation of the rectum and colon. The disease usually lasts long term and the symptoms include diarrhea with blood and abdominal pain. It can also result in inflammations in several body parts and can also lead to colon cancer.

The causes for the disease include genetics, dysfunction of immune system and some other factors. Endoscopy through the rectum is one of the best diagnostic options for ulcerative colitis. There are numerous medications available for the disease ranging from drugs to surgery. The risk of fatalities in patients with the disease is very low.

Due to the changing lifestyles of people with unhealthy diets, prevalence of ulcerative colitis has increased. Increase in investments in pharmaceutical industries for the development of novel drugs, growing risk of acquiring colon cancer and growing healthcare expenditure are expected to propel the market growth. However, strict regulations on product approvals especially biosimilars and chances of recurrence of the disease are hindering the market growth.

The Ulcerative Colitis market is segmented by product, type, route of administration and region. By product, the market is categorized into Monoclonal Antibodies, Biosimilars and Pharmaceuticals. Biosimilars hold the largest market share due to their high production in the last decade due to the patent expiration of branded drugs. Monoclonal antibodies segment is the fastest growing segment due to their effectiveness at curing the disease. By type, the market is categorized into Proctosigmoiditis, Ulcerative Proctitis, Pancolitis and Left sided Colitis. Proctosigmoiditis is the most common type of ulcerative colitis and hence it holds the major market share. By route of administration, the market is categorized into Oral and Injectable products.

On the basis of region, the Asia Pacific Ulcerative Colitis market is segmented into China, India, Japan, Australia and South Korea. Asia Pacific is expected to be the fastest growing market. It is due to the developing healthcare sector in emerging countries such as India through government intervention and expansions of major pharmaceutical companies to this region.

Some of the major players in Ulcerative Colitis market are Abbott Laboratories, GlaxoSmithKline, Pfizer, Takeda Pharmaceuticals, AbbVie, Johnson and Johnson, Merck, Sanofi, F. Hoffmann-La Roche and Shire Pharmaceuticals.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Monoclonal Antibodies                     

                                                5.1.2.1 Humira  

                                                5.1.2.2 Simponi                

                                                5.1.2.3 Remicade             

                                                5.1.2.4 Entyvio  

                                5.1.3 Biosimilars                               

                                5.1.4 Pharmaceuticals                   

                                                5.1.4.1 Mesalamine        

                                                                5.1.4.1.1 Asacol HD

                                                                5.1.4.1.2 Pentasa

                                                                5.1.4.1.3 Lialda

                                                                5.1.4.1.4 sfRowasa

                                                5.1.4.2 Balsazide              

                                                                5.1.4.2.1 Colazal

                                                                5.1.4.2.2 Giazo

                                                5.1.4.3 Budesonide        

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

                5.2 Type                                              

                                5.2.1 Introduction                           

                                5.2.2 Proctosigmoiditis                  

                                5.2.3 Ulcerative Proctitis                              

                                5.2.4 Pancolitis                 

                                5.2.5 Left-sided Colitis                   

                                5.2.5 Y-o-Y Growth Analysis, By Type                     

                                5.2.6 Market Attractiveness Analysis, By Type                   

                                5.2.7 Market Share Analysis, By Type                     

                5.3 Route of Administration                                       

                                5.3.1 Introduction                           

                                5.3.2 Oral                            

                                5.3.3 Injectable                

                                5.3.4 Y-o-Y Growth Analysis, By Route of Administration                               

                                5.3.5  Market Attractiveness Analysis, By Route of Administration                            

                                5.3.6  Market Share Analysis, By Route of Administration                             

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Type 

                                                6.1.3.4 By Route of Administration          

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Type 

                                                6.1.4.4 By Route of Administration          

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Type 

                                                6.1.5.4 By Route of Administration          

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Abbott Laboratories                                               

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 GlaxoSmithKline                                       

                8.3 Pfizer                                            

                8.4 Takeda Pharmaceuticals                                       

                8.5 AbbVie                                         

                8.6 Johnson and Johnson                                            

                8.7 Merck                                           

                8.8 Sanofi                                           

                8.9 F. Hoffmann-La Roche                                           

                8.10 Shire Pharmaceuticals                                         

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Market Outlook and Investment Opportunities                                                         

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms By Route Of Administration with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Ulcerative Colitis Market By Product, From 2018-2023 ( USD Billion )
  2. Asia Pacific Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Billion )
  3. Asia Pacific Biosimilars Market By Region, From 2018-2023 ( USD Billion )
  4. Asia Pacific Pharmaceuticals Market By Region, From 2018-2023 ( USD Billion )
  5. Asia Pacific Ulcerative Colitis Market By Type, From 2018-2023 ( USD Billion )
  6. Asia Pacific Proctosigmoiditis Market By Region, From 2018-2023 ( USD Billion )
  7. Asia Pacific Ulcerative Proctitis Market By Region, From 2018-2023 ( USD Billion )
  8. Asia Pacific Pancolitis Market By Region, From 2018-2023 ( USD Billion )
  9. Asia Pacific Left sided Colitis Market By Region, From 2018-2023 ( USD Billion )
  10. Asia Pacific Ulcerative Colitis Market By Route of Administration, From 2018-2023 ( USD Billion )
  11. Asia Pacific Oral Market By Region, From 2018-2023 ( USD Billion )
  12. Asia Pacific Injectable Market By Region, From 2018-2023 ( USD Billion )
  13. Japan Ulcerative Colitis Market By Product, From 2018-2023 ( USD Billion )
  14. Japan Ulcerative Colitis Market By Type, From 2018-2023 ( USD Billion )
  15. Japan Ulcerative Colitis Market By Route of Administration, From 2018-2023 ( USD Billion )
  16. China Ulcerative Colitis Market By Product, From 2018-2023 ( USD Billion )
  17. China Ulcerative Colitis Market By Type, From 2018-2023 ( USD Billion )
  18. China Ulcerative Colitis Market By Route of Administration, From 2018-2023 ( USD Billion )
  19. India Ulcerative Colitis Market By Product, From 2018-2023 ( USD Billion )
  20. India Ulcerative Colitis Market By Type, From 2018-2023 ( USD Billion )
  21. India Ulcerative Colitis Market By Route of Administration, From 2018-2023 ( USD Billion )
  22. Australia Ulcerative Colitis Market By Product, From 2018-2023 ( USD Billion )
  23. Australia Ulcerative Colitis Market By Type, From 2018-2023 ( USD Billion )
  24. Australia Ulcerative Colitis Market By Route of Administration, From 2018-2023 ( USD Billion )
  25. South Korea Ulcerative Colitis Market By Product, From 2018-2023 ( USD Billion )
  26. South Korea Ulcerative Colitis Market By Type, From 2018-2023 ( USD Billion )
  27. South Korea Ulcerative Colitis Market By Route of Administration, From 2018-2023 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample